MSK Cancer Center Orders Staff to ‘Do a Better Job’ of Disclosing Industry Ties
In an email to staff members, chief executives at Memorial Sloan Kettering responded to news that a top doctor had failed to report links to companies in research articles.
View ArticleTop Sloan Kettering Cancer Doctor Resigns After Failing to Disclose Industry...
Dr. José Baselga, the cancer center’s chief medical officer, stepped down days after a report that he had not reported millions of dollars as potential conflicts in dozens of research articles.
View ArticleImmune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds
Combining immunotherapy and chemotherapy can help women with an aggressive type of breast cancer and should become their new standard of care.
View ArticleF.D.A. Approves New Drug for Flu
The new drug, sold as Xofluza, is about as effective as Tamiflu in shortening flu symptoms, and is expected to work against drug-resistant strains.
View ArticleLasker Awards Honor Advances in Modern Immunology
The prizes recognized the discoverers of B and T lymphocytes, pioneers in genetic engineering to fight breast cancer, and a nonprofit that helps get vaccines to the world’s poorest children.
View ArticleRegeneron Funneled Kickbacks Through a Patient Charity, Federal Lawsuit Claims
The case is the latest inquiry into pharmaceutical companies’ donations to patient assistance charities, which have been blamed for inflating the cost of drugs.
View ArticleArthur D. Riggs, 82, Dies; Led Team That Invented Artificial Insulin
His research into recombinant DNA provided a foundation for the biotech revolution, leading to a long list of lifesaving treatments.
View ArticleStanford President Resigns After Report Finds Flaws in his Research
Marc Tessier-Lavigne was cleared of accusations of scientific fraud and misconduct. But the review said his work had “multiple problems” and “fell below customary standards of scientific rigor.”
View ArticleWhat To Know About the Stanford President’s Resignation
An expert panel found fault, but not misconduct, in several neuroscience papers by Marc Tessier-Lavigne. Here are the details.
View ArticleDrug Drastically Reduces Children’s Reactions to Traces of Food Allergens
Xolair cuts the risk of dangerous reactions after exposure to minute amounts of allergens, researchers reported. But people taking it still must avoid risky foods.
View Article
